相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。New trends in platinum and palladium complexes as antineoplastic agents
Mirco Fanelli et al.
COORDINATION CHEMISTRY REVIEWS (2016)
Risk of Vascular Toxicity with Platinum Based Chemotherapy in Elderly Patients with Bladder Cancer
Amit Gupta et al.
JOURNAL OF UROLOGY (2016)
Biological evaluation of a novel Herceptin-platinum (II) conjugate for efficient and cancer cell specific delivery
Rong Huang et al.
BIOMEDICINE & PHARMACOTHERAPY (2015)
Anti-growth effect of a novel trans-dichloridobis[2-(2-hydroxyethyl)pyridine] platinum (II) complex via induction of apoptosis on breast cancer cell lines
Arzu Yilmaztepe Oral et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Association of Wnt-Inducible Signaling Pathway Protein 1 Genetic Polymorphisms With Lung Cancer Susceptibility and Platinum-Based Chemotherapy Response
Juan Chen et al.
CLINICAL LUNG CANCER (2015)
Pharmacokinetics and tissue distribution of novel platinum containing anticancer agent BP-C1 studied in rabbits using sector field inductively coupled plasma mass spectrometry
Denis V. Navolotskii et al.
DRUG TESTING AND ANALYSIS (2015)
Synthesis, structural characterization and in vitro anti-cancer activity of functionalized N-heterocyclic carbene platinum and palladium complexes
Georges Dahm et al.
JOURNAL OF ORGANOMETALLIC CHEMISTRY (2015)
Caffeine derived platinum(II) N-heterocyclic carbene complexes with multiple anti-cancer activities
Jing-Jing Zhang et al.
JOURNAL OF ORGANOMETALLIC CHEMISTRY (2015)
Simultaneous quantitation of two diastereoisomers of lobaplatin in rat plasma by supercritical fluid chromatography with tandem mass spectrometry and its application to a pharmacokinetic study
Xiangjun Meng et al.
JOURNAL OF SEPARATION SCIENCE (2015)
The metallobiochemistry of ultratrace levels of platinum group elements in the rat
E. Sabbioni et al.
METALLOMICS (2015)
Plasma pharmacokinetics and tissue and brain distribution of cisplatin in musk shrews
Julie L. Eiseman et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2015)
Optimization of carboxylate-terminated poly(amidoamine) dendrimer-mediated cisplatin formulation
Hitesh Kulhari et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2015)
Synthesis, anticancer activity and toxicity of a water-soluble 4S,5S-derivative of heptaplatin, cis-{Pt(II)[(4S,5S)-4,5-bis(aminomethyl)-2-isopropyl-1,3-dioxolane].(3-hydroxyl-cyclobutane-1,1-dicarboxylate)}
Weiping Liu et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2014)
In vivo biodistribution of platinum-based drugs encapsulated into multi-walled carbon nanotubes
Jian Li et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2014)
Investigation on pharmacokinetics, tissue distribution and excretion of a novel platinum anticancer agent in rats by Inductively Coupled Plasma Mass Spectrometry (ICP-MS)
Jie Zhao et al.
XENOBIOTICA (2014)
Improved pharmacological profile of the lipophilic antitumor dichloro-(N-dodecyl)-propanediamine-platinum(II) complex after incorporation into pegylated liposomes
Heveline Silva et al.
ANTI-CANCER DRUGS (2013)
ET AAS evaluation of the stability and pH-sensitivity of, pH-sensitive stealth liposomes containing cisplatin in mouse plasma
F. P. Vieira et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2013)
Pharmacokinetics, Tissue Distribution, and Plasma Protein Binding Study of Platinum Originating from Dicycloplatin, a Novel Antitumor Supramolecule, in Rats and Dogs by ICP-MS
Di Zhao et al.
BIOLOGICAL TRACE ELEMENT RESEARCH (2012)
A Novel Water-Soluble Heptaplatin Analogue with Improved Antitumor Activity and Reduced Toxicity
Weiping Liu et al.
INORGANIC CHEMISTRY (2011)
Determination of platinum originated from antitumoral drugs in human urine by atomic absorption spectrometric methods
Anilton Coelho da Costa Junior et al.
TALANTA (2010)
Investigation on pharmacokinetics, tissue distribution and excretion of a novel anticancer platinum compound by inductively coupled plasma mass spectrometry after intravenous administration to rats
Qing-fei Liu et al.
ARCHIVES OF PHARMACAL RESEARCH (2009)
Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate
Shanta Dhar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Antitumor activity and biodistribution of cisplatin nanocapsules in nude mice bearing human ovarian carcinoma xenografts
Rutger W. H. M. Staffhorst et al.
ANTI-CANCER DRUGS (2008)
Pharmacokinetic investigation on a novel antitumour platinum compound in rabbit plasma by lnductively coupled plasma mass spectrometry after intravenous administration
Qiang Su et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2008)
Insight into the reactive form of the anticancer agent iproplatin
Erika Volckova et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2008)
Molecular mechanisms of resistance and toxicity associated with platinating agents
Cara A. Rabik et al.
CANCER TREATMENT REVIEWS (2007)
Tissue distribution evaluation of stealth pH-sensitive liposomal cisplatin versus free cisplatin in Ehrlich tumor-bearing mice
Alvaro D. C. Junior et al.
LIFE SCIENCES (2007)
Satraplatin activation by haemoglobin, cytochrome C and liver microsomes in vitro
JL Carr et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2006)
Determination of cisplatin and its hydrolytic metabolite in human serum by capillary electrophoresis techniques
Z Huang et al.
JOURNAL OF CHROMATOGRAPHY A (2006)
Analysis of cytotoxicities of platinum compounds
J Goodisman et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2006)
Liquid chromatographic determination of cis-platin as platinum(II) in pharmaceutical preparation, serum and urine samples of cancer patients
MY Khuhawar et al.
TALANTA (2005)
Pharmacokinetics and tissue distribution of platinum in rats following single and multiple oral doses of LA-12 [(OC-6-43)bis(acetato)(1-adamantylamine)amminedichloroplatinum(IV)]
P Sova et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2005)
Novel separation method for highly sensitive speciation of cancerostatic platinum compounds by HPLC-ICP-MS
S Hann et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2005)
Platinum(IV) complex with adamantylamine as nonleaving amine group:: Synthesis, characterization, and in vitro antitumor activity against a panel of cisplatin-resistant cancer cell lines
F Zák et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Liquid chromatographic determination of oxaliplatin in blood using post-column derivatization in a microwave field followed by photometric detection
H Ehrsson et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2003)
Platinum-based anticancer agents: Innovative design strategies and biological perspectives
YP Ho et al.
MEDICINAL RESEARCH REVIEWS (2003)
Determination of carboplatin in plasma and tumor by high-performance liquid chromatography-mass spectrometry
P Guo et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2003)
Pharmaceutical development of a parenteral lyophilized formulation of the investigational polymer-conjugated platinum anticancer agent AP 5280
M Bouma et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2003)
Elements in environmental and occupational medicine
P Apostoli
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2002)
Molecular-weight-dependent pharmacokinetics and cytotoxic properties of cisplatin complexes prepared with chondroitin sulfate A and C
JS Zhang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2002)
Particular aspects of platinum compounds used at present in cancer treatment
B Desoize et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2002)
Validation of a highly sensitive ICP-MS method for the determination of platinum in biofluids: application to clinical pharmacokinetic studies with oxaliplatin
JG Morrison et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2000)
Low-level (PPB) determination of cisplatin in cleaning validation (rinse water) samples. I. An atomic absorption spectrophotometric method
R Raghavan et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2000)
分享论文
